Design
Review
Authors
Loading...
Cardioprotection remains an unmet need in acute MI; leaves open validation of molecular targets in prospective trials.
Key points are not available for this paper at this time.
Derek M. Yellon (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: